These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2370079)

  • 1. Effects of the MHC on hormonal induction of mammary tumors and function of hypophyseal isografts in the mouse.
    Röpcke G; Moen CJ; Hart AA; Demant P
    Immunogenetics; 1990; 31(5-6):347-55. PubMed ID: 2370079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC-controlled susceptibility to C3H-MTV-induced mouse mammary tumors is predominantly systemic rather than local.
    Dux A; Demant P
    Int J Cancer; 1987 Sep; 40(3):372-7. PubMed ID: 3040602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse strain (STS/A) resistant to mammary tumor induction by hypophysial isografts.
    van der Gugten AA; Röpcke G; van Nie R; Hilgers J
    Cancer Res; 1985 Aug; 45(8):3448-53. PubMed ID: 4016729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary tumors in BALB/cfC3H and BALB/cfRIII virgin female mice bearing hypophyseal isografts.
    Pingitore R
    Tumori; 1982 Oct; 68(5):389-92. PubMed ID: 6294936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mouse major histocompatibility complex (H-2) on N-ethyl-N-nitrosourea-induced tumor formation in various organs.
    Oomen LC; van der Valk MA; Hart AA; Demant P; Emmelot P
    Cancer Res; 1988 Dec; 48(23):6634-41. PubMed ID: 3180072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractoriness to mammary carcinogenesis in the parous mouse is reversible by hormonal stimulation induced by pituitary isografts.
    Swanson SM; Guzman RC; Collins G; Tafoya P; Thordarson G; Talamantes F; Nandi S
    Cancer Lett; 1995 Apr; 90(2):171-81. PubMed ID: 7736453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC haplotype influences primary Giardia muris infections in H-2 congenic strains of mice.
    Venkatesan P; Finch RG; Wakelin D
    Int J Parasitol; 1993 Aug; 23(5):661-4. PubMed ID: 8225770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of susceptibility to experimental autoimmune uveoretinitis in the mouse model. Concomitant regulation by MHC and non-MHC genes.
    Caspi RR; Grubbs BG; Chan CC; Chader GJ; Wiggert B
    J Immunol; 1992 Apr; 148(8):2384-9. PubMed ID: 1560198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC and non-MHC genes in lung tumor susceptibility in the mouse: implications for the study of the different lung tumor types and their cell of origin.
    Oomen LC; van der Valk MA; Demant P
    Exp Lung Res; 1991; 17(2):283-304. PubMed ID: 2050032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cyclosporin on major histocompatibility complex-linked resistance to murine cytomegalovirus.
    Lawson CM; Hodgkin PD; Shellam GR
    J Gen Virol; 1989 May; 70 ( Pt 5)():1253-9. PubMed ID: 2543779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of progesterone in DNA synthesis of pregnancy-dependent mammary tumors in mice.
    Yanai R; Nagasawa H
    Int J Cancer; 1976 Sep; 18(3):317-21. PubMed ID: 986372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors.
    Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL
    Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The H-2 class II genes and the susceptibility to the development of pulmonary adenoma in mice.
    Miyashita N; Moriwaki K; Migita S
    Immunogenetics; 1989; 29(1):14-8. PubMed ID: 2783252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice.
    McGrath CM; Prass WA; Maloney TM; Jones RF
    J Natl Cancer Inst; 1981 Oct; 67(4):841-52. PubMed ID: 6268884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analyses of differences in incidence of mammary tumors and reticulum cell neoplasms with the use of recombinant inbred lines of mice.
    Dux A; Mühlbock O; Bailey DW
    J Natl Cancer Inst; 1978 Oct; 61(4):1125-9. PubMed ID: 212568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High estrogen and low progestin receptor levels in outgrowths of hypophyseal isografts.
    Sluyser M; Boot LM; Röpcke G
    Cancer Res; 1978 Sep; 38(9):2859-60. PubMed ID: 679193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum, pituitary and urine concentrations of prolactin and growth hormone in eight strains of mice with varying incidence of mammary tumors.
    Sinha YN; Vlahakis G; Vanderlaan WP
    Int J Cancer; 1979 Oct; 24(4):430-7. PubMed ID: 528068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse major histocompatibility complex and lung development: haplotype variation, H-2 immunolocalization, and progressive maturation.
    Jaskoll T; Hu CC; Melnick M
    Am J Med Genet; 1991 Jun; 39(4):422-36. PubMed ID: 1877621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H2 complex controls CD4/CD8 ratio, recurrent responsiveness to repeated stimulations, and resistance to activation-induced apoptosis during T cell response to mycobacterial antigens.
    Pichugin AV; Petrovskaya SN; Apt AS
    J Leukoc Biol; 2006 Apr; 79(4):739-46. PubMed ID: 16415170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the major histocompatibility complex (H-2) on glucocorticoid-stimulated pulmonary surfactant synthesis in two congenic mouse strains.
    Honig LS; Smith BT; Slavkin HC; Donahue HG
    Proc Soc Exp Biol Med; 1984 Sep; 176(4):419-25. PubMed ID: 6547777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.